SEC Form 4 · accession 0000899243-15-005185
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gillian C Ivers-Read
Officer — See Remarks
Period of report
Sep 18, 2015
Accepted (ET)
Sep 22, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 18, 2015 | S | 3,000 | $112.56 | D | 215,583 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2015.
Remarks
Executive Vice President of Technical Operations and Chief Regulatory Officer